Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Assurant (AIZ) Shares Outstanding (Diluted Average) (2016 - 2026)

Assurant has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $51.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 1.86% year-over-year to $51.1 million; the TTM value through Dec 2025 reached $51.1 million, down 1.86%, while the annual FY2025 figure was $51.1 million, 1.86% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $51.1 million at Assurant, up from $525846.0 in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $60.9 million in Q3 2021 and troughed at $144071.0 in Q2 2023.
  • A 5-year average of $22.5 million and a median of $991568.5 in 2021 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 99.63% in 2023 and later soared 17167.82% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $60.1 million in 2021, then decreased by 8.88% to $54.8 million in 2022, then tumbled by 99.4% to $327930.0 in 2023, then soared by 15773.19% to $52.1 million in 2024, then decreased by 1.86% to $51.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for AIZ at $51.1 million in Q4 2025, $525846.0 in Q3 2025, and $51.6 million in Q2 2025.